MedPath

Santen Pharmaceutical (Hong Kong) Limited

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

26

PPB:26

Drug Approvals

RHOPRESSA EYE DROPS 0.02% W/V

Approval Date
Jun 19, 2024
PPB

ROCKLATAN EYE DROPS

Approval Date
Feb 26, 2024
PPB

DUCRESSA EYE DROPS

Approval Date
Mar 22, 2022
PPB

COSOPT-S OPHTHALMIC SOLUTION

Approval Date
Apr 4, 2018
PPB

TAPCOM OPHTHALMIC SOLUTION

Approval Date
Feb 13, 2018
PPB

IKERVIS EYE DROPS, EMULSION 1MG/ML

Approval Date
Mar 31, 2017
PPB

CRAVIT OPHTHALMIC SOLUTION 1.5%W/V

Approval Date
Nov 4, 2016
PPB

TAPCOM-S OPHTHALMIC SOLUTION

Approval Date
Aug 9, 2016
PPB

TAFLOTAN-S OPHTHALMIC SOLUTION 0.0015%W/V

Approval Date
Jun 8, 2015
PPB

HIALID 0.3 OPHTHALMIC SOLUTION 0.3%W/V

Approval Date
Mar 10, 2015
PPB
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.